ALNYLAM PHARMACEUTICALS, INC. [ALNY]

Source: 

Company Overview

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company developing novel therapeutics based on ribonucleic acid interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression.